{"nct_id":"NCT01111825","title":"Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer","status":"COMPLETED","status_verified_date":"2018-08","start_date":"2010-04","start_date_type":"ACTUAL","primary_completion_date":"2016-07","primary_completion_date_type":"ACTUAL","completion_date":"2016-07","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["PBYI"]}